On the basis of the statistical analysis of sequencing data from the Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA) cohorts, researchers have shown that high SEC61G expression is significantly associated with poor prognosis in glioblastoma patients. Here, SEC61G is linked to glioblastoma.